Are you going to #ESUR2024 ? We'll be exhibiting and presenting a poster! See you in Lisbon from 19-22 September 2024 🇵🇹

Welcome to the Aug. 7 #RadAIchat at 8 PM ET on "Checklist for #AI in Medical Imaging (CLAIM): 2024 Update" moderated by Mike Klontzas and panelists Lisa Adams Charles Kahn, MD Ali Tejani, MD #radiomics #DL RSNA Hesham Elhalawani Please introduce yourself and always remember to add #RadAIchat

Proud to share the results of this fruitful cooperation! Andrea Ponsiglione Renato Cuocolo Evis Sala Arnaldo Stanzione ESUR Junior Network Details on European Radiology ⬇️ #Radiomics #EndometrialCancer #MRI

Meet Mark, our CTO, a Physicist with 30 years of experience in complex systems and clinical trial programs for major pharmaceutical, biotech, and medical device companies. Former CTO at IAG and Tech Director at Fitch Ratings.

We'll be exhibiting at #RSNA24! Come and see us at the Lucida Medical booth to see a demo of our groundbreaking software Pi™ (Prostate Intelligence™). #RSNA2024 #radtwitter

EAU-EANM- ESTRO -ESUR-ISUP-SIOG Guidelines on Prostate Cancer—2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent out on European Urology europeanurology.com/article/S0302-… The 2024 European Association of Urology European Association of Urology (EAU) guidelines on clinically localized

Excellent overview of prostate MRI reporting best practice by Benjamin Spilseth, Francesco Giganti Francesco Giganti & Silvia Chang, covering diagnosis, quality, recurrence, monitoring and treatment and new technologies like AI. doi.org/10.1007/s00261…

Introducing David, with 20+ years in medical imaging and pharma, is Chairman of several med-tech firms. Ex-CEO of Lightpoint Medical, acquired by Telix. He held roles at GE, Novartis, and Harvard. He holds a PhD from MIT/Harvard and a BA from University of Chicago.

Watch this demo presented by John La on prostate cancer fusion biopsy, using Lucida Medical’s Pi™ and Focal Healthcare's Fusion Bx system. Discover how advanced tech is revolutionising prostate cancer diagnosis. vimeo.com/999568289

We'll be exhibiting at 'Shaping the future of AI in healthcare: Learning from practice - Global AI Conference' organised by the Royal College of Radiologists, in London from 3-4 February 2025. Abstract submission deadline: 16 September⌛️ The Royal College of Radiologists rcr.ac.uk/cpd-and-events…

Prostate Cancer Diagnosis Pathway Update delivered at #ESUR2024, by Prof Anwar Padhani. Anwar Padhani #ESUR24 ESUR Junior Network European Society of Urogenital Radiology youtu.be/PPvYiHiSmNc?si…

Meet Lucy, Head of Clinical Strategy, with 15 years experience in clinical research and medical stats including developing prostate cancer trials at the University of Oxford.

Prof. Anwar Padhani discusses the evolving landscape of prostate cancer diagnosis. From early detection to patient preferences, Anwar Padhani explores the role of AI, and what changes to expect in future for the MRI diagnostic pathway. #ExpertInsights lucidamedical.com/latest-news/

Genomic and epigenomic analysis of plasma cell-free DNA identifies stemness features associated with worse survival in lethal prostate cancer Out on Clinical Cancer Research Study investigates metastatic castration-resistant #ProstateCancer (mCRPC) resistant to androgen receptor signaling

Two weeks to go till #ESUR2024! See Dr Francesco Giganti present our abstract during Thursday's Scientific Session, from 16.00 on 19 September. Register here: lisbon2024.esur.org ESUR Junior Network European Society of Urogenital Radiology Francesco Giganti #radtwitter #ESUR24

In this short film Dr. Olly Hulson discuss using AI to address growing challenges in prostate cancer diagnosis. vimeo.com/958264736